Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 3/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12394 | 0.86 | KMT2A (0.54) | KMT2AALDH1A1GAAMEN1LMNA | |
| Ammonia Solution, Strong SCHEMBL8909178 | 0.84 | KMT2A (0.52) | KMT2AALDH1A1GAAMEN1LMNA | |
| Phosphine SCHEMBL28772208 | 0.84 | KMT2A (0.52) | KMT2AALDH1A1GAAMEN1LMNA | |
| Hydrogen Sulfide SCHEMBL27992657 | 0.84 | KMT2A (0.52) | KMT2AALDH1A1GAAMEN1LMNA | |
| Hydrochloric Acid SCHEMBL6570767 | 0.81 | KMT2A (0.50) | KMT2AALDH1A1GAAMEN1LMNA | |
| Ethylene SCHEMBL28227817 | 0.81 | KMT2A (0.50) | KMT2AALDH1A1GAAMEN1LMNA | |
| Methylamine SCHEMBL27820445 | 0.81 | KMT2A (0.50) | KMT2AALDH1A1GAAMEN1LMNA | |
| SCHEMBL7959053 | 0.81 | CYP1A2 (0.41) | KMT2AALDH1A1GAAMEN1LMNA | |
| SCHEMBL28153666 | 0.79 | KMT2A (0.49) | KMT2AALDH1A1GAAMEN1LMNA | |
| SCHEMBL27469399 | 0.79 | LMNA (0.53) | KMT2AGAAMEN1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118047699-A | Preparation method of 4-isopropoxy benzenesulfonyl chloride | 武威广达科技有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-121779283-A | Process for synthesizing 4-isopropoxy benzenesulfonyl chloride | 大连双硼医药化工有限公司 | 2026-04-03 | — | — | CN | disclosed |
| CN-118047699-A | Preparation method of 4-isopropoxy benzenesulfonyl chloride | 武威广达科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-106463627-B | Photovoltaic element | 东丽株式会社 | 2019-06-28 | — | — | CN | disclosed |
| CN-106892920-A | Aloperine derivative, preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2017-06-27 | — | — | CN | disclosed |
| CN-104520288-B | Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists | 坎莫森特里克斯公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-106463627-A | Photovoltaic element | 东丽株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-106008288-A | Benzsulfamide compound and application thereof | 西北农林科技大学 | 2016-10-12 | — | — | CN | disclosed |
| CN-103265501-B | Method for producing N-phenyl-N'-phenylsulfonylpiperazine derivative | SHIONOGI & CO | 2015-06-03 | — | — | CN | disclosed |
| CN-104520288-A | Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists | CHEMOCENTRYX | 2015-04-15 | — | — | CN | disclosed |
| US-20070149603-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON, INC. | 2007-06-28 | — | — | US | disclosed |
| US-7202266-B2 | PPAR active compounds | PLEXXIKON, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| CN-1845898-A | PPAR active compounds | PLEXXIKON INC (US) | 2006-10-11 | — | — | CN | disclosed |
| EP-1648867-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2006-04-26 | — | — | EP | disclosed |
| US-20050288354-A1 | PPAR active compounds | PLEXXIKON, INC. | 2005-12-29 | — | — | US | disclosed |
| CN-1711257-A | Aryl sulfonamides | CHEMOCENTRYX (US) | 2005-12-21 | — | — | CN | disclosed |
| CN-1617855-A | Cytosolic phospholipase A2Inhibitors | WYETH CORP (US) | 2005-05-18 | — | — | CN | disclosed |
| US-20050038246-A1 | PPAR active compounds | PLEXXIKON, INC. | 2005-02-17 | — | — | US | disclosed |
| WO-2005009958-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| CN-86100964-A | The preparation method of piperidine compounds | — | 1986-10-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038246-A1 | PPAR active compounds | PPARG, PPARD, PPARA | KMT2A 3773/4885ALDH1A1 1171/4885GAA 1372/4885 |
| US-20050288354-A1 | PPAR active compounds | PPARG, PPARD, PPARA | KMT2A 3773/4885ALDH1A1 1171/4885GAA 1372/4885 |
| US-20070149603-A1 | PPAR ACTIVE COMPOUNDS | PPARG, PPARD, PPARA | KMT2A 3773/4885ALDH1A1 1171/4885GAA 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.